[ad_1] Bengaluru: The U.S. Centers for Disease Control and Prevention is planning to issue a travel notice for China as mosquito-borne chikungunya infections rise in the country, Bloomberg News reported on Wednesday. “CDC is aware of the reported chikungunya outbreak in Guangdong Province in China and is currently assessing the size and extent of the…
[ad_1] Mumbai: Maharashtra chief minister Devendra Fadnavis on Tuesday said “abrupt” closure of kabutarkhanas (pigeon feeding spots) in the city was not advisable, and asked the Brihanmumbai Municipal Corporation (BMC) to ensure controlled feeding of the birds. The chief minister’s statement has come amid growing demand for the closure of traditional ‘kabutarkhanas’ in Mumbai over…
[ad_1] New Delhi: Healthcare technology company FUJIFILM India introduced ENDOVEDA, a new digital endoscopy reporting platform, at the Endocon 2025 conference held in Jaipur. The company states that the platform is developed entirely in India. It is intended to support clinicians with structured documentation and workflow efficiency during endoscopic procedures. According to the company, ENDOVEDA…
[ad_1] Sandoz Streamlines More Trials As First-Half Biosimilars Sales Hit $1.5bn Offers Update On Portfolio And Pipeline Following H1 Growth Sandoz is streamlining more biosimilar trials (Shutterstock) Share current article via EmailShare current article via TwitterShare current article via LinkedIn [ad_2] Source link
Strand Therapeutics raises $153M to advance mRNA therapies targeting cancer, enhancing the immune response against tumors.
XtalPi collaborates with DoveTree Medicines to enhance AI-driven drug discovery, reflecting a trend in biotech partnerships.
Minghui Pharmaceutical raises $131M for PD-1xVEGF bispecific, advancing its oncology pipeline amid growing investor interest.
The courts uphold Medicare drug price negotiations, impacting pharma strategies and reinforcing government authority under the IRA.
FDA launches a program to streamline the construction of drug manufacturing sites in the U.S., enhancing domestic production capabilities.
J&J receives a CRL from the FDA due to manufacturing issues, highlighting challenges in regulatory compliance.
In a significant legal development, the US Appeals Court has rejected Boehringer Ingelheim’s constitutional arguments against Medicare drug price negotiations, impacting pharmaceutical pricing strategies and potentially reshaping industry dynamics. The ruling holds implications for market access, regulatory decisions, and overall pricing structures within the pharma sector. Government Regulations in Focus With this decision, the government…
The FDA has introduced a new program aimed at expediting the construction of drug manufacturing sites in the US. This initiative is poised to enhance the resilience of the pharmaceutical supply chain, diminish dependence on international production, and potentially augment the nation’s capacity for domestic drug manufacturing. By accelerating the establishment of manufacturing facilities, the…
Strand Therapeutics Secures $153 Million to Advance mRNA Cancer Immunotherapy Trials Strand Therapeutics has announced the successful completion of a $153 million funding round dedicated to advancing its mRNA cancer immunotherapy trials. This significant financial milestone exemplifies a critical step forward in the realm of cancer treatment. The infusion of $153 million into Strand Therapeutics…
Source XtalPi Teams Up with DoveTree Medicines to Revolutionize AI Drug Discovery XtalPi and DoveTree Medicines have recently embarked on a groundbreaking collaboration in the realm of AI drug discovery, signaling a significant advancement in the pharmaceutical landscape. Key Strategic Implications: Business Development: The alliance between XtalPi and DoveTree Medicines presents a strategic avenue to…
